UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

FORM SD

 

 

 

Specialized Disclosure Report

 

  NOVO NORDISK A/S  
(Exact name of the registrant as specified in its charter)
 
The Kingdom of Denmark 333-82318 N/A
(State or other jurisdiction of
Incorporation or organization) 		(Commission
File Number) 		(IRS Employer
Identification No.)
     
Novo Allé, DK-2880 Bagsværd, Denmark   N/A
(Address of principal executive offices)   (Zip code)
     
Karsten Munk Knudsen +45 4444 8888
(Name and telephone number, including area code, of the
person to contact in connection with this report.)
       
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
 
  X     Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2018.

 

 

 

Section 1 - Conflict Minerals Disclosure

 

Items 1.01 and 1.02 Conflict Minerals Disclosure and Report, Exhibit

 

Conflict Minerals Disclosure

 

A copy of Novo Nordisk A/S’s Conflict Minerals Report for the year ended December 31, 2018 is provided as Exhibit 1.01 hereto and is publicly available at: https://www.novonordisk.com/sustainable-business/performance-on-tbl/more-about-how-we-work-and-report/transparency-disclosures.html

 

Section 2 – Exhibits

 

Item 2.01 Exhibits

 

Exhibit 1.01 – Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

 

Date: May 22, 2019 NOVO NORDISK A/S
   
   
  By: /s/ Karsten Munk Knudsen
  Name: Karsten Munk Knudsen
  Title: Executive Vice President & Chief Financial Officer

 

 

 

 

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Novo Nordisk Charts.
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Novo Nordisk Charts.